Printer friendly
Acronymfinder

What does MRFIT stand for?

MRFIT stands for Multiple Risk Factor Intervention Trial


This definition appears very frequently and is found in the following Acronym Finder categories:

  • Science, medicine, engineering, etc.

Samples in periodicals archive:

In the Multiple Risk Factor Intervention Trial, patients given HCTZ by investigators had 44% more coronary heart disease and 16% more deaths after 5 years of follow-up, compared with control patients cared for in the community by primary care physicians (Circulation 1990;82:1616-28).
The men studied by Walker's group were a subset of participants in the Multiple Risk Factor Intervention Trial (MRFIT), an even larger study evaluating measures to prevent heart disease among men at risk for the disorder because of cigarette smoking, elevated blood cholesterol, or elevated blood pressure.
The findings were from the Multiple Risk Factor Intervention Trial (MRFIT), a randomized controlled trial of 12,866 men with a mean age of 46 years.
Studies such as the Multiple Risk Factor Intervention Trial (MRFIT), an epidemiologic study of 316,099 men with an average follow-up of 12 years, have shown that even mild-to-moderate levels of both hypertension (systolic blood pressure [SBP] 132-141 mm Hg) and dyslipidemia (total cholesterol 221-244 mg/dL) can impart risk for coronary heart disease (CHD) that is similar or greater than that due to severe elevations of either risk factor alone.
Studies such as the Multiple Risk Factor Intervention Trial (MRFIT), an epidemiologic study of 316,099 men with an average follow-up of 12 years, have shown that even mild-to-moderate levels of both hypertension (systolic blood pressure [SBP] 132-141 mm Hg) and dyslipidemia (total cholesterol 221-244 mg/dL) can impart risk for coronary heart disease (CHD) that is similar or greater than that due to severe elevations of either risk factor alone.
Studies such as the Multiple Risk Factor Intervention Trial (MRFIT), an epidemiologic study of 316,099 men with an average follow-up of 12 years, have shown that even mild-to-moderate levels of both hypertension (systolic blood pressure [SBP] 132-141 mm Hg) and dyslipidemia (total cholesterol 221-244 mg/dL) can impart risk for coronary heart disease (CHD) that is similar or greater than that due to severe elevations of either risk factor alone.
Studies such as the Multiple Risk Factor Intervention Trial (MRFIT), an epidemiologic study of 316,099 men with an average follow-up of 12 years, have shown that even mild-to-moderate levels of both hypertension (systolic blood pressure [SBP] 132-141 mm Hg) and dyslipidemia (total cholesterol 221-244 mg/dL) can impart risk for coronary heart disease (CHD) that is similar or greater than that due to severe elevations of either risk factor alone.
Studies such as the Multiple Risk Factor Intervention Trial (MRFIT), an epidemiologic study of 316,099 men with an average follow-up of 12 years, have shown that even mild-to-moderate levels of both hypertension (systolic blood pressure [SBP] 132-141 mm Hg) and dyslipidemia (total cholesterol 221-244 mg/dL) can impart risk for coronary heart disease (CHD) that is similar or greater than that due to severe elevations of either risk factor alone.